Masonglory Limited heads into mid-May with one signal standing well above all others: the cost to borrow these shares has nearly doubled in two months, even as actual short positioning remains thin.
The borrow story is the defining feature of this name right now. Cost to borrow has climbed to 128.3% annualised — up 28% on the week and 68% over the past month. To put that in context, it was sitting near 53% as recently as early April. Yet availability in the lending pool remains extremely loose. Utilisation on May 12 was just 7%, down sharply from 23% the prior session and a fraction of its 52-week peak near 98%. That divergence — sky-high borrow rates alongside ample share availability — is unusual. It points to a fragmented, illiquid borrow market where pricing is driven by the mechanics of finding shares rather than genuine crowding by short sellers. The ORTEX short score of 46, down from a recent high of 54 on May 11, reflects a setup that is elevated but not extreme.
Short interest in absolute terms tells a quieter story. Estimated shares short edged down 10% on May 12 to around 87,000 shares, after spiking to nearly 97,000 the prior session. Over the trailing week the position is still up roughly 14%, but with a market cap of just $6.4 million and a share price of $0.45, the actual dollar exposure involved is negligible. FINRA's most recent fortnightly figure puts official short interest at roughly 55,000 shares with days-to-cover under one day — suggesting what movement there is gets absorbed quickly in a stock with this level of turnover.
The broader picture is one of persistent price pressure. The stock fell 11% over the past month and is down 83% year-to-date, closing at $0.4493 on May 12 after a 4% bounce in the most recent session. The RSI of 40 signals the stock is weak but not yet technically oversold, and there are no analyst ratings or price targets on record to frame a bull or bear case. Ownership is highly concentrated: Fung & Tun Limited holds nearly 74% of shares, and that anchor position has been trimmed by 1 million shares as of January. The only other notable institutional activity is from quantitative firms — Quadrature Capital added 159,000 shares through year-end 2025.
Earnings are next scheduled for June 26. The recent history is mixed at best: the September 2025 print prompted a 13% one-day gain but was followed by an 85% five-day collapse, while the December 2025 release saw a 3% single-day drop and further losses over the following week. Given the scale of the year-to-date decline, the next release is less a story about growth expectations and more a test of whether the company can arrest the deterioration in sentiment around the name.
See the live data behind this article on ORTEX.
Open MSGY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
